Table 3.
Phylum | Family | Genus | Physiological Effects/Associations Previously Detected |
---|---|---|---|
Actinobacteria ↑ [68] |
Eggerthellaceae | Adlercreutzia ↓ [66] |
Higher abundance in patients with back pain and positively correlated with BMI and inflammation [73] |
Bifidobacteriaceae | Bifidobacterium ↑ [67] ↑ [61] |
Inhibit pathogens [74] Modulation of intestinal and systemic immune responses [74] Vitamin production [75] ↓ Inflammation [76], ↓ LPS [77] |
|
Firmicutes ↓ [64] |
Erysipelotrichaceae | Coprobacillus ↓ [66] |
Positive correlation with frailty and associated with biological ageing [78] |
Ruminococcaceae | Ruminococcus ↑ [67] |
Degrade and convert complex polysaccharides into a variety of nutrientsButyrate producers This genus has been associated with depression in some studies, although some species have anti-depressive effects [79] |
|
Faecalibacterium ↑ [65] |
↓ Inflammation [80,81] Butyrate production [82] Protect against colon cancer [83] |
||
Oscillospira ↑ [63] ↑ [61] |
Negatively associated with metabolic disturbances [84] Associated with leanness and ↓BMI [84,85] |
||
Clostridiaceae ↑ [68] |
Clostridioides XI ↑ [67] |
Increased in autistic children [86] | |
Peptostreptococcaceae | Clostridioides ↓ [63] (C. difficile) ↓ [64] |
Genus with several well-known pathogens (e.g. C. difficile) ↑ Inflammation [87] Alteration of gut microbiota composition [87] |
|
Lachnospiraceae ↑ [64,67] |
Roseburia ↑ [64] |
SCFAs production [88] Anti-inflammatory effects Abundance decreases concomitantly with muscle mass and dysfunction [89] |
|
Anaerostipes ↑ [61] |
Production of acetate and butyrate [90] Beneficial role on renal function [91] |
||
Oribacterium ↓ [61] |
Higher proportions were found in obese subjects [92] | ||
Selenomonadaceae | Mitsuokella ↑ [64] |
Butyrate production [93] | |
Streptococcaceae | Streptococcus ↓ [67] |
Involved in the development of metabolic disorders, diabetes and colon cancer. Increases inflammation [94] | |
Bacteroidetes | Bacteroidaceae ↑ [68] ↓ [64] |
Negatively correlated with body weight and fasted plasma insulin [95]. Members of this genus can be beneficial for the host and can be pathogenic as well, depending on several factors such as the taxonomical composition, geographic location or diet. | |
Prevotellaceae | Prevotella ↑ [67] ↓ [61] |
Beneficial for the GI tract and human health Propionate producersSome studies found that specific strains from the genus might be involved in inflammation [96] |
|
Paraprevotella ↑ [68] |
Succinate and acetate producers [97] Reduced abundance in low functioning older adults [98] and sedentary women [99] Reduced abundance is associated with several diseases [100,101] |
||
Proteobacteria | Oxalobactereaceae ↓ [68] |
Increased abundance in cholangiocarcinoma patients [102] Increased abundance in patients with knee osteoarthritis [103] |
|
Sutterellaceae | Parasutterella ↓ [65] |
Associated with IBS genesis and development [104] Associated with obesity, diabetes and fatty liver disease [65] |
|
Desulfovribionaceae | Bilophila ↓ [65] |
Produces H2S which has cytotoxic effects on the gut membrane and inhibits butyrate production [105] Higher abundance induces systemic inflammation [106] |
|
Enterobacteriaceae | Escherichia ↓ [64] |
This family has been associated with IBD and other GI tract diseases [107] LPS producers Pro-inflammatory |
|
Succinivibrionaceae | Succinivibrio ↓ [61] |
Fiber degradation and typical in diets with high fibre and complex carbohydrates [108] | |
Verrucomicrobia | Akkermansiaceae | Akkermansia ↑ [64] |
Decreased abundance was correlated with increased BMI [109] ↑ Insulin sensitivity and glucose tolerance [109] Reduces total cholesterol [110] Decreases fat mass [110] |
We only included taxonomical changes that were statistically significant, ↑ Increased after or positively associated with exercise/physical activity, ↓ Decreased after or negatively associated with exercise/physical activity, METs—Metabolic syndrome; IBD (inflammatory bowel disease); LPS (lipopolysaccharide); UC (ulcerative colitis); GI (gastrointestinal); SCFAs (short-chain fatty acids); NAFDL (non-alcoholic fatty liver disease); TLR4 (toll-like receptor 4); BMI (body mass index); TG (triglycerides).